Serological immunoreactivity against colon cancer proteome varies upon disease progression.

Serological immunoreactivity against colon cancer proteome varies upon disease progression.

Item
http://www.wikidata.org/entity/Q40027849
Proteome serological determination of tumor-associated antigens in melanoma.Proteome-based analysis of serologically defined tumor-associated antigens in cutaneous lymphomaImmunoscreening of the extracellular proteome of colorectal cancer cells.Differential influence of anticancer treatments and angiogenesis on the seric titer of autoantibody used as tumor and metastasis biomarker.Identification of β-tubulin as a common immunogen in gastrointestinal malignancy by mass spectrometry of colorectal cancer proteome: implications for early disease detection.Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer.An Optimized Fluorescence-Based Bidimensional Immunoproteomic Approach for Accurate Screening of Autoantibodies.Oncoproteomics: Trials and tribulations.Serological immune response against ADAM10 pro-domain is associated with favourable prognosis in stage III colorectal cancer patientsDeveloping proteomics-based biomarkers for colorectal neoplasms for clinical practice: opportunities and challenges.Natural Antibodies to Tumor-Associated Antigens.A possible role of transglutaminase 2 in the nucleus of INS-1E and of cells of human pancreatic isletsA proteomic profile of washing fluid from the colorectal tract to search for potential biomarkers of colon cancer
P2860

Serological immunoreactivity against colon cancer proteome varies upon disease progression.

Item
http://www.wikidata.org/entity/Q40027849
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Serological immunoreactivity a ...... ries upon disease progression.
@en
type
label
Serological immunoreactivity a ...... ries upon disease progression.
@en
prefLabel
Serological immunoreactivity a ...... ries upon disease progression.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Serological immunoreactivity a ...... ries upon disease progression.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698